Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 20, 2019

View Archived Issues

Exosome-derived miRNAs from colon cancer cells promote fibroblast proliferation and tumor growth

Bone-deep stress

CAR relative CCR may offer targeting advantages

Rare eye disease gives clues to peripheral neuropathy

Researchers unveil the role of vasorin in angiogenesis and tumor progression in glioma

CinDome Pharma initiates phase II study of deuterated domperidone

PDS Biotechnology presents phase I data for its novel immunotherapy PDS-0101

Positive topline results presented from phase III study of contezolid in cSSTI

NfL as biomarker for early diagnosis of polyneuropathy in patients with hATTR amyloidosis

Melflufen plus dexamethasone show encouraging activity in advanced RRMM with EMD

LUBAC identified as a biomarker of prognosis and potential therapeutic target in lung cancer

SASH1 as a predictive biomarker for sensitivity to PARP inhibitors

Phase Ib data on IMCY-0098 in young adults with recent-onset type 1 diabetes presented

U.S. investigators patent KRAS mutant inhibitors

Dart NeuroScience divulges new OPRL1 antagonists

Incyte presents new adenosine A2A and/or A2B receptor antagonists

Annapurna Bio discovers apelin receptor agonists

Caveolin-1 deficiency links type 2 diabetes to sporadic AD

Takeda Pharmaceutical identifies somatostatin SST4 receptor agonists

Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Y-Trap, Merck KGaA announce immuno-oncology collaboration

Lasvic approved in Japan to treat respiratory and ENT infections

A1M reports initial phase Ia data on ROSgard

Aslan reports phase II data from Chinese study of varlitinib in second-line biliary tract cancer

Grand Challenge grant supports University of Chicago-led development of universal influenza vaccine

Affibody collaborates with GE Healthcare to develop Affibody-based PET imaging tracers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...